A great team milestone: IPO at Nasdaq

Here's the full ceremony from when we IPO'ed at Nasdaq, including a speech from our CEO, Michael Heltzen.

Leadership Team

Our management team has vast experience with startups and scale-ups, as well as multiple successful exits.
25_A8641

Chief Executive Officer

Michael Heltzen
25_A8726-edited

Chief Commercial Officer

Damien Perriman
25_A8620-edited2

Co-Founder, Chief Scientific Officer

Tyler Korman
25_A8517

Co-Founder, VP of Development

Paul Opgenorth
25_A8772-edited

VP of Finance

Fouad Nawaz
25_A8660

VP of Communications

Lasse Görlitz
25_A8809

Chief of Staff

Amy Lunzer
25_A8547

Director, Biosolutions

John Billingsley
James

Director, Engineering

James Fang
25_A8569 (1)

Director, Operations

Erika Vielmas
25_A8604

Team Lead, Biosolutions

Adrian Brückner
25_A8526

Team Lead, Enzyme Engineering

Bastian Vögeli
25_A8557

Team Lead, Protein Production

Alexi Bardha
25_A9143

The history of our company

Our co-founders, Tyler Korman, PhD, and Paul Opgenorth, PhD, share how the basic idea - liberating the enzymes from the confines of working in cells - was hatched in Jim Bowie's lab at UCLA, before being spun out as Invizyne in 2019, including some of the projects and challenges along the way.

Come work with the most ambitious (and fun) team in biomanufacturing!

EXOZ-TEAM

Join us and work somewhere you can be yourself. And grow!

We are innovators and forward thinkers. We value creativity and appreciate your strength in executing the fundamentals. Above all, we are motivated by our commitment to great work and to each other.

We continue to grow. To learn more about opportunities to join our team, check back here often.

 
Click to see potential job openings

Want to be kept up to date?

We are excited to keep you updated with news tailored to your preferences. By subscribing to one or more streams, you'll receive information relevant to the areas you've selected. If you ever wish to update your preferences, you can do so at any time.